

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.72483656 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 4.60548663 |
| 3 | DNA deamination (GO:0045006) | 4.54004879 |
| 4 | protein maturation by protein folding (GO:0022417) | 4.48624697 |
| 5 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.45608811 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 4.42383230 |
| 7 | nucleobase biosynthetic process (GO:0046112) | 4.37628380 |
| 8 | DNA strand elongation (GO:0022616) | 4.27256181 |
| 9 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.22833501 |
| 10 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.19684788 |
| 11 | purine nucleobase biosynthetic process (GO:0009113) | 4.16587286 |
| 12 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 4.16060354 |
| 13 | DNA replication initiation (GO:0006270) | 4.08287462 |
| 14 | DNA unwinding involved in DNA replication (GO:0006268) | 4.02106691 |
| 15 | IMP biosynthetic process (GO:0006188) | 4.00006067 |
| 16 | pentose-phosphate shunt (GO:0006098) | 3.99750806 |
| 17 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.97811004 |
| 18 | glucose 6-phosphate metabolic process (GO:0051156) | 3.89494056 |
| 19 | peptidyl-arginine methylation (GO:0018216) | 3.88472427 |
| 20 | peptidyl-arginine N-methylation (GO:0035246) | 3.88472427 |
| 21 | histone arginine methylation (GO:0034969) | 3.88415924 |
| 22 | maturation of SSU-rRNA (GO:0030490) | 3.83102800 |
| 23 | regulation of translational fidelity (GO:0006450) | 3.80363009 |
| 24 | telomere maintenance via recombination (GO:0000722) | 3.73036989 |
| 25 | protein retention in ER lumen (GO:0006621) | 3.71187352 |
| 26 | IMP metabolic process (GO:0046040) | 3.67147130 |
| 27 | glucose catabolic process (GO:0006007) | 3.64347682 |
| 28 | protein localization to kinetochore (GO:0034501) | 3.61267088 |
| 29 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.58224587 |
| 30 | ribosome biogenesis (GO:0042254) | 3.57904851 |
| 31 | proline biosynthetic process (GO:0006561) | 3.55018798 |
| 32 | DNA replication checkpoint (GO:0000076) | 3.52559671 |
| 33 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.47110900 |
| 34 | mitotic nuclear envelope disassembly (GO:0007077) | 3.45005395 |
| 35 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.44054039 |
| 36 | NADPH regeneration (GO:0006740) | 3.43547023 |
| 37 | mitotic recombination (GO:0006312) | 3.43179238 |
| 38 | establishment of viral latency (GO:0019043) | 3.42770601 |
| 39 | mitotic nuclear envelope reassembly (GO:0007084) | 3.36052225 |
| 40 | nuclear envelope reassembly (GO:0031468) | 3.36052225 |
| 41 | Golgi transport vesicle coating (GO:0048200) | 3.33442846 |
| 42 | COPI coating of Golgi vesicle (GO:0048205) | 3.33442846 |
| 43 | establishment of integrated proviral latency (GO:0075713) | 3.30680934 |
| 44 | pinocytosis (GO:0006907) | 3.26104860 |
| 45 | pentose metabolic process (GO:0019321) | 3.25764901 |
| 46 | GDP-mannose metabolic process (GO:0019673) | 3.24749791 |
| 47 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.24308770 |
| 48 | viral transcription (GO:0019083) | 3.22053470 |
| 49 | telomere maintenance via telomere lengthening (GO:0010833) | 3.21956276 |
| 50 | UV protection (GO:0009650) | 3.21303424 |
| 51 | glycolytic process (GO:0006096) | 3.18885678 |
| 52 | translational termination (GO:0006415) | 3.18809634 |
| 53 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.18492602 |
| 54 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.18492602 |
| 55 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.14803706 |
| 56 | mitotic metaphase plate congression (GO:0007080) | 3.13885454 |
| 57 | nuclear envelope disassembly (GO:0051081) | 3.13883140 |
| 58 | membrane disassembly (GO:0030397) | 3.13883140 |
| 59 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.12633216 |
| 60 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.11731773 |
| 61 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.11628690 |
| 62 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.10222801 |
| 63 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.10222801 |
| 64 | translational elongation (GO:0006414) | 3.08751359 |
| 65 | ribosomal large subunit biogenesis (GO:0042273) | 3.06473629 |
| 66 | negative regulation of cell size (GO:0045792) | 3.06432201 |
| 67 | translational initiation (GO:0006413) | 3.06384953 |
| 68 | nucleotide salvage (GO:0043173) | 3.05962907 |
| 69 | nuclear pore organization (GO:0006999) | 3.05626419 |
| 70 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.05527186 |
| 71 | protein localization to chromosome, centromeric region (GO:0071459) | 3.04215103 |
| 72 | ribosome assembly (GO:0042255) | 3.03419299 |
| 73 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.99772821 |
| 74 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.99761139 |
| 75 | protein targeting to ER (GO:0045047) | 2.99067264 |
| 76 | cotranslational protein targeting to membrane (GO:0006613) | 2.98997677 |
| 77 | proteasome assembly (GO:0043248) | 2.95736336 |
| 78 | rRNA modification (GO:0000154) | 2.95409266 |
| 79 | modulation by virus of host process (GO:0019054) | 2.93246239 |
| 80 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.92626828 |
| 81 | pseudouridine synthesis (GO:0001522) | 2.92387029 |
| 82 | viral mRNA export from host cell nucleus (GO:0046784) | 2.92271536 |
| 83 | rRNA processing (GO:0006364) | 2.91110865 |
| 84 | mitotic chromosome condensation (GO:0007076) | 2.90385195 |
| 85 | negative regulation of RNA splicing (GO:0033119) | 2.90356043 |
| 86 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.88534380 |
| 87 | spliceosomal snRNP assembly (GO:0000387) | 2.87021887 |
| 88 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.86051149 |
| 89 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.85154920 |
| 90 | protein localization to endoplasmic reticulum (GO:0070972) | 2.84792226 |
| 91 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84777492 |
| 92 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.84764660 |
| 93 | nucleosome disassembly (GO:0006337) | 2.83180993 |
| 94 | protein-DNA complex disassembly (GO:0032986) | 2.83180993 |
| 95 | L-serine metabolic process (GO:0006563) | 2.83077918 |
| 96 | telomere organization (GO:0032200) | 2.82482990 |
| 97 | ribosomal small subunit biogenesis (GO:0042274) | 2.82427056 |
| 98 | telomere maintenance (GO:0000723) | 2.82378963 |
| 99 | rRNA metabolic process (GO:0016072) | 2.81782589 |
| 100 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.81636452 |
| 101 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.81517897 |
| 102 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.80398428 |
| 103 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.79413421 |
| 104 | regulation of mitochondrial translation (GO:0070129) | 2.79256161 |
| 105 | protein insertion into membrane (GO:0051205) | 2.79031515 |
| 106 | chromatin remodeling at centromere (GO:0031055) | 2.78976335 |
| 107 | NADH metabolic process (GO:0006734) | 2.78750312 |
| 108 | CENP-A containing nucleosome assembly (GO:0034080) | 2.78702569 |
| 109 | snRNA metabolic process (GO:0016073) | 2.78698261 |
| 110 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.77426545 |
| 111 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.77001359 |
| 112 | folic acid metabolic process (GO:0046655) | 2.76622407 |
| 113 | maternal placenta development (GO:0001893) | 2.75544515 |
| 114 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.75389258 |
| 115 | DNA replication-independent nucleosome organization (GO:0034724) | 2.75389258 |
| 116 | establishment of chromosome localization (GO:0051303) | 2.75259789 |
| 117 | metaphase plate congression (GO:0051310) | 2.74989213 |
| 118 | DNA duplex unwinding (GO:0032508) | 2.74751751 |
| 119 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.74134711 |
| 120 | DNA geometric change (GO:0032392) | 2.73834241 |
| 121 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.73800997 |
| 122 | termination of RNA polymerase II transcription (GO:0006369) | 2.73081755 |
| 123 | modulation by symbiont of host cellular process (GO:0044068) | 2.72203513 |
| 124 | mitochondrial fusion (GO:0008053) | 2.71058799 |
| 125 | * mRNA splicing, via spliceosome (GO:0000398) | 2.70972484 |
| 126 | * RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.70972484 |
| 127 | * RNA splicing, via transesterification reactions (GO:0000375) | 2.69503129 |
| 128 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.68978949 |
| 129 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.68661260 |
| 130 | regulation of spindle organization (GO:0090224) | 2.68648379 |
| 131 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.67679118 |
| 132 | lipopolysaccharide metabolic process (GO:0008653) | 2.67622754 |
| 133 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.67269926 |
| 134 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.66338896 |
| 135 | termination of RNA polymerase III transcription (GO:0006386) | 2.66338896 |
| 136 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.66061403 |
| 137 | translation (GO:0006412) | 2.65099699 |
| 138 | GMP metabolic process (GO:0046037) | 2.64043743 |
| 139 | pyrimidine-containing compound salvage (GO:0008655) | 2.63514350 |
| 140 | pyrimidine nucleoside salvage (GO:0043097) | 2.63514350 |
| 141 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.63346029 |
| 142 | base-excision repair (GO:0006284) | 2.63031779 |
| 143 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.62714788 |
| 144 | negative regulation of mRNA metabolic process (GO:1903312) | 2.62589821 |
| 145 | tRNA methylation (GO:0030488) | 2.60990262 |
| 146 | cell cycle G1/S phase transition (GO:0044843) | 2.60941786 |
| 147 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.60941786 |
| 148 | postreplication repair (GO:0006301) | 2.59900173 |
| 149 | negative regulation of ligase activity (GO:0051352) | 2.59234090 |
| 150 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.59234090 |
| 151 | nuclear pore complex assembly (GO:0051292) | 2.58754308 |
| 152 | response to peptidoglycan (GO:0032494) | 2.58586499 |
| 153 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.58087328 |
| 154 | monosaccharide biosynthetic process (GO:0046364) | 2.57923608 |
| 155 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.57762494 |
| 156 | apoptotic process involved in morphogenesis (GO:0060561) | 2.57136405 |
| 157 | barbed-end actin filament capping (GO:0051016) | 2.57055291 |
| 158 | rRNA transcription (GO:0009303) | 2.56703602 |
| 159 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.56054076 |
| 160 | protein localization to endosome (GO:0036010) | 2.55983027 |
| 161 | translesion synthesis (GO:0019985) | 2.55605643 |
| 162 | positive regulation of nuclease activity (GO:0032075) | 2.54706869 |
| 163 | viral life cycle (GO:0019058) | 2.54369901 |
| 164 | negative regulation of B cell apoptotic process (GO:0002903) | 2.54114549 |
| 165 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.53104550 |
| 166 | DNA-templated transcription, termination (GO:0006353) | 2.52425148 |
| 167 | negative regulation of mRNA processing (GO:0050686) | 2.50517291 |
| 168 | mitotic sister chromatid segregation (GO:0000070) | 2.50337754 |
| 169 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.45323046 |
| 170 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.44851635 |
| 171 | snRNA processing (GO:0016180) | 2.44482453 |
| 172 | proline metabolic process (GO:0006560) | 2.43036901 |
| 173 | tricarboxylic acid metabolic process (GO:0072350) | 2.42253533 |
| 174 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.41821706 |
| 175 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.41621635 |
| 176 | protein export from nucleus (GO:0006611) | 2.41131242 |
| 177 | NIK/NF-kappaB signaling (GO:0038061) | 2.40343309 |
| 178 | tRNA aminoacylation for protein translation (GO:0006418) | 2.39859712 |
| 179 | cellular response to interleukin-4 (GO:0071353) | 2.39540107 |
| 180 | gluconeogenesis (GO:0006094) | 2.38329354 |
| 181 | positive regulation of mitochondrion organization (GO:0010822) | 2.37513122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.19040199 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.77492151 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.73462695 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.96025275 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.85257494 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.69081195 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.65901293 |
| 8 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.62864635 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.58857071 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.58759353 |
| 11 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.58230891 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.57666936 |
| 13 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.56766816 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.50515253 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.49709864 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.26895439 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.26357394 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.23521169 |
| 19 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.13501839 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.11476872 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11292885 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.10390187 |
| 23 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.09528009 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07802981 |
| 25 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.06544971 |
| 26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.92787669 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89841078 |
| 28 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.88621047 |
| 29 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.87548284 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.85461817 |
| 31 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85391046 |
| 32 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84978115 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84623386 |
| 34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.75286425 |
| 35 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72879629 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72628556 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72306799 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69628286 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67957579 |
| 40 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.67557450 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66476316 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.64717464 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62348127 |
| 44 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60309549 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.59542004 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59523639 |
| 47 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59200706 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58822651 |
| 49 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57383196 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55452225 |
| 51 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52319159 |
| 52 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.51058882 |
| 53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50236223 |
| 54 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50224127 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49912107 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.48231908 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47613152 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.47299384 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.46609356 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46293793 |
| 61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.43633519 |
| 62 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.43412320 |
| 63 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.43293275 |
| 64 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43217047 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40188381 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.38974690 |
| 67 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.37516704 |
| 68 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.36829096 |
| 69 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36531399 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34069178 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.32944069 |
| 72 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32826408 |
| 73 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32175295 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30512274 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30088787 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29248246 |
| 77 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.28963250 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28267519 |
| 79 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.27912594 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26699249 |
| 81 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25716184 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22762709 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21788645 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21212824 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21134602 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20324573 |
| 87 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.18521046 |
| 88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18392489 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.17220914 |
| 90 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14146847 |
| 91 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13660545 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13251945 |
| 93 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13102803 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12553685 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12168585 |
| 96 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11843007 |
| 97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11828683 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.11480659 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10810767 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10723428 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09608144 |
| 102 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09561440 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08691831 |
| 104 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08457503 |
| 105 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08004672 |
| 106 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.07604708 |
| 107 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07352670 |
| 108 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06120337 |
| 109 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05508964 |
| 110 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.05444342 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05403897 |
| 112 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05025558 |
| 113 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04721953 |
| 114 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04679342 |
| 115 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.02589533 |
| 116 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01915079 |
| 117 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00964716 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00582628 |
| 119 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00288210 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98446006 |
| 121 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.96523764 |
| 122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96295963 |
| 123 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95799633 |
| 124 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94959586 |
| 125 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94041670 |
| 126 | MAF_26560356_Chip-Seq_TH1_Human | 0.93768537 |
| 127 | MYB_26560356_Chip-Seq_TH1_Human | 0.93417656 |
| 128 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.92549602 |
| 129 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92358122 |
| 130 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92018161 |
| 131 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90338627 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89673481 |
| 133 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88983943 |
| 134 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88793801 |
| 135 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87545084 |
| 136 | MYB_26560356_Chip-Seq_TH2_Human | 0.86291593 |
| 137 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.85768334 |
| 138 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.83874876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.93731982 |
| 2 | MP0008260_abnormal_autophagy | 3.75963732 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.72294282 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.65219713 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.39610456 |
| 6 | MP0003077_abnormal_cell_cycle | 3.21207447 |
| 7 | MP0008058_abnormal_DNA_repair | 2.96597912 |
| 8 | MP0008007_abnormal_cellular_replicative | 2.90086164 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.76372940 |
| 10 | MP0005451_abnormal_body_composition | 2.66983504 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.61043205 |
| 12 | MP0008057_abnormal_DNA_replication | 2.57964743 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.03757444 |
| 14 | MP0001730_embryonic_growth_arrest | 2.03419603 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 1.99745691 |
| 16 | MP0004808_abnormal_hematopoietic_stem | 1.98635981 |
| 17 | MP0004233_abnormal_muscle_weight | 1.87816633 |
| 18 | MP0010307_abnormal_tumor_latency | 1.86789933 |
| 19 | MP0000490_abnormal_crypts_of | 1.85131555 |
| 20 | MP0003329_amyloid_beta_deposits | 1.84072020 |
| 21 | MP0001835_abnormal_antigen_presentation | 1.83936236 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.80286730 |
| 23 | MP0003303_peritoneal_inflammation | 1.75917692 |
| 24 | MP0008932_abnormal_embryonic_tissue | 1.74878444 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.74067803 |
| 26 | MP0002398_abnormal_bone_marrow | 1.73976432 |
| 27 | MP0000350_abnormal_cell_proliferation | 1.73330583 |
| 28 | MP0005501_abnormal_skin_physiology | 1.71172674 |
| 29 | MP0003123_paternal_imprinting | 1.68350166 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.64292071 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.62163724 |
| 32 | MP0000003_abnormal_adipose_tissue | 1.57731869 |
| 33 | MP0002019_abnormal_tumor_incidence | 1.55421651 |
| 34 | MP0001800_abnormal_humoral_immune | 1.55280887 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.55178760 |
| 36 | MP0002722_abnormal_immune_system | 1.54372707 |
| 37 | MP0005671_abnormal_response_to | 1.52176938 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 1.44992828 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.44468821 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.44294188 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.44294188 |
| 42 | MP0003786_premature_aging | 1.43644570 |
| 43 | MP0000313_abnormal_cell_death | 1.43595772 |
| 44 | MP0000604_amyloidosis | 1.42622881 |
| 45 | MP0002429_abnormal_blood_cell | 1.41970945 |
| 46 | MP0000685_abnormal_immune_system | 1.40706606 |
| 47 | MP0000716_abnormal_immune_system | 1.38739285 |
| 48 | MP0008877_abnormal_DNA_methylation | 1.38019637 |
| 49 | MP0002080_prenatal_lethality | 1.36817337 |
| 50 | MP0001697_abnormal_embryo_size | 1.36393929 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.35875697 |
| 52 | MP0009840_abnormal_foam_cell | 1.35615227 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.31765072 |
| 54 | MP0000750_abnormal_muscle_regeneration | 1.30626713 |
| 55 | MP0001672_abnormal_embryogenesis/_devel | 1.29795895 |
| 56 | MP0005380_embryogenesis_phenotype | 1.29795895 |
| 57 | MP0001819_abnormal_immune_cell | 1.29355718 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.27539524 |
| 59 | MP0005083_abnormal_biliary_tract | 1.27518141 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.25816042 |
| 61 | MP0002723_abnormal_immune_serum | 1.24068262 |
| 62 | MP0003436_decreased_susceptibility_to | 1.22561611 |
| 63 | MP0005666_abnormal_adipose_tissue | 1.22236792 |
| 64 | MP0003984_embryonic_growth_retardation | 1.20286088 |
| 65 | MP0006054_spinal_hemorrhage | 1.20217263 |
| 66 | MP0003283_abnormal_digestive_organ | 1.19342413 |
| 67 | MP0002089_abnormal_postnatal_growth/wei | 1.19175190 |
| 68 | MP0002405_respiratory_system_inflammati | 1.18733068 |
| 69 | MP0003186_abnormal_redox_activity | 1.17218238 |
| 70 | MP0002088_abnormal_embryonic_growth/wei | 1.16396236 |
| 71 | MP0004858_abnormal_nervous_system | 1.16178307 |
| 72 | MP0003075_altered_response_to | 1.14469988 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 1.14092580 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.12545141 |
| 75 | MP0002086_abnormal_extraembryonic_tissu | 1.11744961 |
| 76 | MP0002796_impaired_skin_barrier | 1.09591171 |
| 77 | MP0005464_abnormal_platelet_physiology | 1.09573370 |
| 78 | MP0005000_abnormal_immune_tolerance | 1.06256844 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 1.04388471 |
| 80 | MP0000858_altered_metastatic_potential | 1.02663241 |
| 81 | MP0009785_altered_susceptibility_to | 1.02578374 |
| 82 | MP0000358_abnormal_cell_content/ | 1.02558622 |
| 83 | MP0001790_abnormal_immune_system | 1.02509001 |
| 84 | MP0005387_immune_system_phenotype | 1.02509001 |
| 85 | MP0002060_abnormal_skin_morphology | 1.02298908 |
| 86 | MP0005025_abnormal_response_to | 1.00374184 |
| 87 | MP0001853_heart_inflammation | 1.00323067 |
| 88 | MP0002085_abnormal_embryonic_tissue | 0.99962472 |
| 89 | MP0004947_skin_inflammation | 0.99784351 |
| 90 | MP0001849_ear_inflammation | 0.99610654 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.98016027 |
| 92 | MP0009931_abnormal_skin_appearance | 0.97929606 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.97244148 |
| 94 | MP0000678_abnormal_parathyroid_gland | 0.95628196 |
| 95 | MP0002084_abnormal_developmental_patter | 0.95224744 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.94962363 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.94303138 |
| 98 | MP0005076_abnormal_cell_differentiation | 0.91107361 |
| 99 | MP0003943_abnormal_hepatobiliary_system | 0.90801879 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.90681011 |
| 101 | MP0004197_abnormal_fetal_growth/weight/ | 0.90672429 |
| 102 | MP0000747_muscle_weakness | 0.90309009 |
| 103 | MP0002970_abnormal_white_adipose | 0.89625419 |
| 104 | MP0001764_abnormal_homeostasis | 0.89136681 |
| 105 | MP0000598_abnormal_liver_morphology | 0.88713775 |
| 106 | MP0002148_abnormal_hypersensitivity_rea | 0.87424086 |
| 107 | MP0009278_abnormal_bone_marrow | 0.87381888 |
| 108 | MP0009672_abnormal_birth_weight | 0.86749956 |
| 109 | MP0002419_abnormal_innate_immunity | 0.86709760 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.86539366 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.85762166 |
| 112 | MP0001873_stomach_inflammation | 0.85607206 |
| 113 | MP0005023_abnormal_wound_healing | 0.85370690 |
| 114 | MP0002166_altered_tumor_susceptibility | 0.85329013 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.84390288 |
| 116 | MP0000371_diluted_coat_color | 0.84253615 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.82682797 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.82613186 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81048037 |
| 120 | MP0001915_intracranial_hemorrhage | 0.80864991 |
| 121 | MP0000537_abnormal_urethra_morphology | 0.79584073 |
| 122 | MP0003718_maternal_effect | 0.78977133 |
| 123 | MP0005384_cellular_phenotype | 0.78517226 |
| 124 | MP0000477_abnormal_intestine_morphology | 0.76150442 |
| 125 | MP0010771_integument_phenotype | 0.76018598 |
| 126 | MP0001243_abnormal_dermal_layer | 0.75462822 |
| 127 | MP0003119_abnormal_digestive_system | 0.74129865 |
| 128 | MP0008469_abnormal_protein_level | 0.73698771 |
| 129 | MP0005621_abnormal_cell_physiology | 0.73566303 |
| 130 | MP0005075_abnormal_melanosome_morpholog | 0.72683684 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.70665972 |
| 132 | MP0003866_abnormal_defecation | 0.70044548 |
| 133 | MP0003890_abnormal_embryonic-extraembry | 0.69372424 |
| 134 | MP0002653_abnormal_ependyma_morphology | 0.68764349 |
| 135 | MP0006036_abnormal_mitochondrial_physio | 0.68479190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal gallbladder physiology (HP:0012438) | 5.15415458 |
| 2 | Cholecystitis (HP:0001082) | 5.15415458 |
| 3 | Microvesicular hepatic steatosis (HP:0001414) | 4.69680965 |
| 4 | Birth length less than 3rd percentile (HP:0003561) | 3.85170645 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 3.83235175 |
| 6 | Thrombocytosis (HP:0001894) | 3.79627743 |
| 7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.75059276 |
| 8 | J-shaped sella turcica (HP:0002680) | 3.45596955 |
| 9 | Reticulocytopenia (HP:0001896) | 3.43731483 |
| 10 | IgM deficiency (HP:0002850) | 3.40001717 |
| 11 | Hyperacusis (HP:0010780) | 3.31907356 |
| 12 | Aplastic anemia (HP:0001915) | 3.15732673 |
| 13 | Ragged-red muscle fibers (HP:0003200) | 3.12480745 |
| 14 | Petechiae (HP:0000967) | 3.11921920 |
| 15 | Progressive muscle weakness (HP:0003323) | 3.11901593 |
| 16 | Abnormality of B cell number (HP:0010975) | 3.03054819 |
| 17 | B lymphocytopenia (HP:0010976) | 3.03054819 |
| 18 | Degeneration of anterior horn cells (HP:0002398) | 3.02752830 |
| 19 | Abnormality of the anterior horn cell (HP:0006802) | 3.02752830 |
| 20 | Distal upper limb amyotrophy (HP:0007149) | 2.93195177 |
| 21 | Upper limb amyotrophy (HP:0009129) | 2.93195177 |
| 22 | Colon cancer (HP:0003003) | 2.91770124 |
| 23 | Reticulocytosis (HP:0001923) | 2.91510249 |
| 24 | Hand muscle atrophy (HP:0009130) | 2.83067170 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 2.79799898 |
| 26 | Nuclear cataract (HP:0100018) | 2.79687889 |
| 27 | Cholelithiasis (HP:0001081) | 2.78196302 |
| 28 | Abnormality of glycolysis (HP:0004366) | 2.77552705 |
| 29 | Breast hypoplasia (HP:0003187) | 2.73885052 |
| 30 | Oral leukoplakia (HP:0002745) | 2.73631160 |
| 31 | 11 pairs of ribs (HP:0000878) | 2.69413734 |
| 32 | Long palpebral fissure (HP:0000637) | 2.67782988 |
| 33 | Testicular atrophy (HP:0000029) | 2.67395839 |
| 34 | Agnosia (HP:0010524) | 2.66056703 |
| 35 | Selective tooth agenesis (HP:0001592) | 2.63780189 |
| 36 | Squamous cell carcinoma (HP:0002860) | 2.63160488 |
| 37 | Insomnia (HP:0100785) | 2.62732227 |
| 38 | Abnormality of reticulocytes (HP:0004312) | 2.56213284 |
| 39 | Achilles tendon contracture (HP:0001771) | 2.55289670 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.52438524 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.52325995 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51194318 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51194318 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51194318 |
| 45 | Carpal bone hypoplasia (HP:0001498) | 2.51010584 |
| 46 | Patellar aplasia (HP:0006443) | 2.47709723 |
| 47 | Personality changes (HP:0000751) | 2.44246728 |
| 48 | Macrocytic anemia (HP:0001972) | 2.42872097 |
| 49 | Progressive external ophthalmoplegia (HP:0000590) | 2.42862518 |
| 50 | Rough bone trabeculation (HP:0100670) | 2.42579038 |
| 51 | Multiple enchondromatosis (HP:0005701) | 2.41959321 |
| 52 | Vertebral compression fractures (HP:0002953) | 2.38204065 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35842976 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.35842976 |
| 55 | Microretrognathia (HP:0000308) | 2.34489670 |
| 56 | Broad distal phalanx of finger (HP:0009836) | 2.32545696 |
| 57 | Ependymoma (HP:0002888) | 2.31629558 |
| 58 | Trismus (HP:0000211) | 2.31303628 |
| 59 | Medulloblastoma (HP:0002885) | 2.30286659 |
| 60 | Lymphoma (HP:0002665) | 2.30266812 |
| 61 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.28932472 |
| 62 | Megaloblastic anemia (HP:0001889) | 2.28405466 |
| 63 | Impulsivity (HP:0100710) | 2.27951492 |
| 64 | Abnormality of the thoracic spine (HP:0100711) | 2.27613806 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.27301454 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.27109880 |
| 67 | Recurrent bronchitis (HP:0002837) | 2.26051005 |
| 68 | Hypertensive crisis (HP:0100735) | 2.25605746 |
| 69 | Neuronal loss in central nervous system (HP:0002529) | 2.22897218 |
| 70 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.22500500 |
| 71 | Abnormality of the Achilles tendon (HP:0005109) | 2.21668532 |
| 72 | Recurrent viral infections (HP:0004429) | 2.20617258 |
| 73 | Combined immunodeficiency (HP:0005387) | 2.20074042 |
| 74 | Hyperthyroidism (HP:0000836) | 2.19062774 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.17441782 |
| 76 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.16326896 |
| 77 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.16326896 |
| 78 | Abnormal protein glycosylation (HP:0012346) | 2.16326896 |
| 79 | Abnormal glycosylation (HP:0012345) | 2.16326896 |
| 80 | Basal cell carcinoma (HP:0002671) | 2.14957998 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 2.14567964 |
| 82 | Thoracic kyphosis (HP:0002942) | 2.14079214 |
| 83 | Neoplasm of the pancreas (HP:0002894) | 2.13511544 |
| 84 | Upper limb muscle weakness (HP:0003484) | 2.12758782 |
| 85 | Cervical subluxation (HP:0003308) | 2.08689716 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08005359 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08005359 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08005359 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 2.07561580 |
| 90 | Abnormality of the gallbladder (HP:0005264) | 2.07119476 |
| 91 | Poikiloderma (HP:0001029) | 2.06843110 |
| 92 | Seborrheic dermatitis (HP:0001051) | 2.06234467 |
| 93 | Severe combined immunodeficiency (HP:0004430) | 2.05998687 |
| 94 | Abnormality of T cells (HP:0002843) | 2.04972141 |
| 95 | Myelodysplasia (HP:0002863) | 2.04505898 |
| 96 | Increased serum ferritin (HP:0003281) | 2.04260999 |
| 97 | Prolonged neonatal jaundice (HP:0006579) | 2.03810299 |
| 98 | Prominent metopic ridge (HP:0005487) | 2.03542388 |
| 99 | Pallor (HP:0000980) | 2.02943846 |
| 100 | Polygenic inheritance (HP:0010982) | 2.00252811 |
| 101 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.00212355 |
| 102 | Deep palmar crease (HP:0006191) | 1.99853164 |
| 103 | Asymmetry of the thorax (HP:0001555) | 1.99579725 |
| 104 | Cellular immunodeficiency (HP:0005374) | 1.99380287 |
| 105 | Hepatosplenomegaly (HP:0001433) | 1.94935914 |
| 106 | Tongue fasciculations (HP:0001308) | 1.94535234 |
| 107 | Pointed chin (HP:0000307) | 1.94505319 |
| 108 | Loss of speech (HP:0002371) | 1.94010681 |
| 109 | Bone marrow hypocellularity (HP:0005528) | 1.92679135 |
| 110 | Hypoplasia of the thymus (HP:0000778) | 1.91624592 |
| 111 | Absent thumb (HP:0009777) | 1.90173921 |
| 112 | IgG deficiency (HP:0004315) | 1.89896681 |
| 113 | Premature graying of hair (HP:0002216) | 1.89783947 |
| 114 | Increased serum pyruvate (HP:0003542) | 1.89290647 |
| 115 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.89191909 |
| 116 | Granulocytopenia (HP:0001913) | 1.89178056 |
| 117 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.88433283 |
| 118 | Amaurosis fugax (HP:0100576) | 1.87131160 |
| 119 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.85382256 |
| 120 | Growth hormone excess (HP:0000845) | 1.84818051 |
| 121 | Obstructive lung disease (HP:0006536) | 1.83235164 |
| 122 | Chronic obstructive pulmonary disease (HP:0006510) | 1.83235164 |
| 123 | Disproportionate tall stature (HP:0001519) | 1.82957573 |
| 124 | Lymphopenia (HP:0001888) | 1.82907797 |
| 125 | Myopathic facies (HP:0002058) | 1.82186351 |
| 126 | Pancytopenia (HP:0001876) | 1.81533076 |
| 127 | Homocystinuria (HP:0002156) | 1.81461197 |
| 128 | Abnormality of homocysteine metabolism (HP:0010919) | 1.81461197 |
| 129 | Abnormality of chromosome stability (HP:0003220) | 1.81029891 |
| 130 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.80712082 |
| 131 | Late onset (HP:0003584) | 1.80435779 |
| 132 | Abnormal trabecular bone morphology (HP:0100671) | 1.80142017 |
| 133 | IgA deficiency (HP:0002720) | 1.80050809 |
| 134 | Deformed sella turcica (HP:0002681) | 1.79492055 |
| 135 | Colitis (HP:0002583) | 1.76927771 |
| 136 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76751322 |
| 137 | Cerebral hypomyelination (HP:0006808) | 1.75821683 |
| 138 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.74515568 |
| 139 | Missing ribs (HP:0000921) | 1.73499425 |
| 140 | Villous atrophy (HP:0011473) | 1.73256095 |
| 141 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.73256095 |
| 142 | Poor head control (HP:0002421) | 1.72850378 |
| 143 | Severe short stature (HP:0003510) | 1.72467547 |
| 144 | Elfin facies (HP:0004428) | 1.72393296 |
| 145 | Global brain atrophy (HP:0002283) | 1.71461996 |
| 146 | Cellulitis (HP:0100658) | 1.70593142 |
| 147 | Flattened epiphyses (HP:0003071) | 1.70389652 |
| 148 | Optic nerve coloboma (HP:0000588) | 1.70221015 |
| 149 | Slender long bone (HP:0003100) | 1.69814046 |
| 150 | Freckling (HP:0001480) | 1.69480671 |
| 151 | Mediastinal lymphadenopathy (HP:0100721) | 1.69326290 |
| 152 | Cutaneous melanoma (HP:0012056) | 1.67635607 |
| 153 | Apathy (HP:0000741) | 1.67413716 |
| 154 | Premature rupture of membranes (HP:0001788) | 1.67251447 |
| 155 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.66107166 |
| 156 | Agammaglobulinemia (HP:0004432) | 1.65656497 |
| 157 | Vacuolated lymphocytes (HP:0001922) | 1.65437289 |
| 158 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.64855397 |
| 159 | Broad face (HP:0000283) | 1.64618267 |
| 160 | Diminished motivation (HP:0000745) | 1.64044881 |
| 161 | Rhabdomyosarcoma (HP:0002859) | 1.63563255 |
| 162 | Axonal loss (HP:0003447) | 1.63281792 |
| 163 | Orthostatic hypotension (HP:0001278) | 1.63240278 |
| 164 | Peripheral hypomyelination (HP:0007182) | 1.63039671 |
| 165 | Prominent nose (HP:0000448) | 1.62994214 |
| 166 | Abnormality of the preputium (HP:0100587) | 1.62626968 |
| 167 | Recurrent fungal infections (HP:0002841) | 1.62173341 |
| 168 | Muscle fibrillation (HP:0010546) | 1.62101739 |
| 169 | Entropion (HP:0000621) | 1.61636604 |
| 170 | Abnormal neuron morphology (HP:0012757) | 1.61575156 |
| 171 | Abnormality of the motor neurons (HP:0002450) | 1.61575156 |
| 172 | Increased cerebral lipofuscin (HP:0011813) | 1.60365850 |
| 173 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.59363016 |
| 174 | Absent epiphyses (HP:0010577) | 1.59363016 |
| 175 | Athetosis (HP:0002305) | 1.59156971 |
| 176 | Biconcave vertebral bodies (HP:0004586) | 1.58220839 |
| 177 | Truncus arteriosus (HP:0001660) | 1.56890735 |
| 178 | Supranuclear gaze palsy (HP:0000605) | 1.52169657 |
| 179 | Severe visual impairment (HP:0001141) | 1.52062184 |
| 180 | Distal lower limb muscle weakness (HP:0009053) | 1.51545606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.10287773 |
| 2 | SMG1 | 3.93165736 |
| 3 | WEE1 | 3.20841626 |
| 4 | MAP4K1 | 2.90560932 |
| 5 | VRK2 | 2.86416208 |
| 6 | PASK | 2.84876093 |
| 7 | CDC7 | 2.79054853 |
| 8 | PRPF4B | 2.44814168 |
| 9 | TSSK6 | 2.36546850 |
| 10 | ICK | 2.35812291 |
| 11 | FLT3 | 2.23385399 |
| 12 | NEK2 | 2.20837589 |
| 13 | EIF2AK1 | 2.11725863 |
| 14 | BRSK2 | 2.10106442 |
| 15 | ACVR1B | 2.02244629 |
| 16 | NME2 | 2.00554972 |
| 17 | ARAF | 1.94733346 |
| 18 | SIK1 | 1.90247422 |
| 19 | MAP3K10 | 1.86571016 |
| 20 | TESK2 | 1.85569581 |
| 21 | PLK4 | 1.76109272 |
| 22 | SRPK1 | 1.75802721 |
| 23 | SCYL2 | 1.68648760 |
| 24 | CCNB1 | 1.66148218 |
| 25 | TTK | 1.63815634 |
| 26 | EIF2AK3 | 1.63738792 |
| 27 | STK16 | 1.62981808 |
| 28 | KDR | 1.60284548 |
| 29 | CSF1R | 1.55070031 |
| 30 | EEF2K | 1.51423383 |
| 31 | ATR | 1.49583946 |
| 32 | STK10 | 1.49359929 |
| 33 | BRSK1 | 1.48394012 |
| 34 | SIK2 | 1.46009885 |
| 35 | PKN2 | 1.45590632 |
| 36 | RPS6KA4 | 1.44590942 |
| 37 | ERN1 | 1.41970202 |
| 38 | PLK1 | 1.39840774 |
| 39 | CDK7 | 1.39658642 |
| 40 | TESK1 | 1.38937418 |
| 41 | RPS6KB2 | 1.34832629 |
| 42 | TLK1 | 1.30121256 |
| 43 | BTK | 1.26281485 |
| 44 | ZAP70 | 1.25784234 |
| 45 | BCKDK | 1.25504099 |
| 46 | AURKB | 1.24224283 |
| 47 | MAP3K8 | 1.23893014 |
| 48 | TGFBR1 | 1.22760205 |
| 49 | VRK1 | 1.21718309 |
| 50 | MAPK15 | 1.20529789 |
| 51 | DYRK3 | 1.20017800 |
| 52 | MAP3K11 | 1.18372953 |
| 53 | PIM2 | 1.18004126 |
| 54 | CDK4 | 1.17776537 |
| 55 | SIK3 | 1.17567226 |
| 56 | RIPK4 | 1.07361791 |
| 57 | KIT | 1.07263396 |
| 58 | EPHA2 | 1.06190840 |
| 59 | NEK1 | 1.03797084 |
| 60 | PIM1 | 1.02861304 |
| 61 | GRK6 | 1.01603919 |
| 62 | MKNK1 | 0.98209446 |
| 63 | CHEK2 | 0.97823459 |
| 64 | PAK4 | 0.95688494 |
| 65 | MAPK11 | 0.95200583 |
| 66 | AURKA | 0.90117915 |
| 67 | MAP2K3 | 0.89635079 |
| 68 | IRAK4 | 0.87353525 |
| 69 | LMTK2 | 0.85856507 |
| 70 | ILK | 0.82697277 |
| 71 | MAP3K13 | 0.82495527 |
| 72 | LIMK1 | 0.81931815 |
| 73 | CHEK1 | 0.80851210 |
| 74 | MAP3K3 | 0.80615964 |
| 75 | TEC | 0.80404412 |
| 76 | CDK12 | 0.80110374 |
| 77 | FGFR4 | 0.78212012 |
| 78 | MAP2K2 | 0.77792626 |
| 79 | BRD4 | 0.74969405 |
| 80 | PLK3 | 0.74285584 |
| 81 | LRRK2 | 0.72117297 |
| 82 | STK4 | 0.71112156 |
| 83 | BLK | 0.71110076 |
| 84 | MAP2K6 | 0.70939443 |
| 85 | PTK6 | 0.70800312 |
| 86 | SYK | 0.70533119 |
| 87 | TBK1 | 0.68958296 |
| 88 | CLK1 | 0.67011414 |
| 89 | TYK2 | 0.66649592 |
| 90 | IRAK3 | 0.65590680 |
| 91 | TAOK3 | 0.65494752 |
| 92 | CDK9 | 0.65048032 |
| 93 | JAK3 | 0.64643765 |
| 94 | TGFBR2 | 0.64627326 |
| 95 | RIPK1 | 0.63783441 |
| 96 | TAOK2 | 0.63331108 |
| 97 | CDK2 | 0.63105542 |
| 98 | CHUK | 0.60590313 |
| 99 | CSNK2A2 | 0.59471301 |
| 100 | CDK8 | 0.59227044 |
| 101 | CDK11A | 0.59148761 |
| 102 | MAP3K1 | 0.58313724 |
| 103 | PDK2 | 0.56592103 |
| 104 | PRKCI | 0.56241284 |
| 105 | CSNK2A1 | 0.55763672 |
| 106 | MKNK2 | 0.55679243 |
| 107 | PTK2 | 0.55378439 |
| 108 | ATM | 0.55244053 |
| 109 | ALK | 0.54842261 |
| 110 | ZAK | 0.54231180 |
| 111 | TRIB3 | 0.54110596 |
| 112 | CDK15 | 0.53720132 |
| 113 | PRKD3 | 0.52829634 |
| 114 | LYN | 0.52728476 |
| 115 | EIF2AK2 | 0.52525256 |
| 116 | DAPK3 | 0.51812243 |
| 117 | TAF1 | 0.51753518 |
| 118 | TAOK1 | 0.51744753 |
| 119 | NME1 | 0.51305770 |
| 120 | PRKD2 | 0.50037057 |
| 121 | CDK18 | 0.49169546 |
| 122 | RPS6KA2 | 0.48009808 |
| 123 | ABL2 | 0.47340698 |
| 124 | AKT2 | 0.46566419 |
| 125 | NTRK1 | 0.46023663 |
| 126 | CDK14 | 0.45929886 |
| 127 | RAF1 | 0.45235867 |
| 128 | MAPKAPK3 | 0.44745386 |
| 129 | BRAF | 0.44623292 |
| 130 | PDPK1 | 0.43022149 |
| 131 | DAPK1 | 0.42656980 |
| 132 | IRAK2 | 0.42137180 |
| 133 | PAK1 | 0.40530651 |
| 134 | MARK2 | 0.40198378 |
| 135 | EPHB1 | 0.40186099 |
| 136 | NLK | 0.39017157 |
| 137 | IKBKB | 0.38261308 |
| 138 | LCK | 0.35170697 |
| 139 | HIPK2 | 0.34355016 |
| 140 | RPS6KL1 | 0.34102554 |
| 141 | RPS6KC1 | 0.34102554 |
| 142 | MAP3K14 | 0.34025029 |
| 143 | MTOR | 0.33697775 |
| 144 | BMX | 0.32427292 |
| 145 | CDK6 | 0.31930774 |
| 146 | CDK1 | 0.31381022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.60128001 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.73988781 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.13994331 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.01067240 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 2.94347290 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.91582663 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.90524542 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.90299314 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.88388780 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.54999566 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.44252281 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.41516223 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.38108810 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.30830265 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.19359345 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.12876706 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.11943667 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.05191014 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.68692136 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53346127 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.50999615 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47004360 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.42447000 |
| 24 | RNA degradation_Homo sapiens_hsa03018 | 1.41819512 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35832186 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32210474 |
| 27 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.32004561 |
| 28 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.29811214 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.28657598 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26814978 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26490075 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26268433 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.21466582 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21106005 |
| 35 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.20975775 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 1.18391380 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17888996 |
| 38 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.15928244 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.14464497 |
| 40 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12123823 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09895514 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05702877 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.05607383 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04038143 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03024541 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02700389 |
| 47 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.00742046 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.98661452 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96917430 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96805319 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92120282 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89967464 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86953864 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85712096 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82434085 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.80981566 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80747985 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80520711 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79979989 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78508393 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76057346 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.75728949 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74164849 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67899448 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67833928 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64173196 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63434327 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.62473087 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61084242 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.59103360 |
| 71 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.58610595 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57800454 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56671809 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56268254 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.54175448 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.52824300 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52060927 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.51901859 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50668906 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49981760 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.49738511 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48894653 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47895710 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47535575 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.47250450 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45399499 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.44915424 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44685285 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44419493 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44407196 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44065123 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.44042656 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43163822 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42395512 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42138696 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.41998564 |
| 97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40832921 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40649076 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38789440 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38640350 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37427938 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.37111705 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35417253 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.35266808 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34538577 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34291039 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33586737 |
| 108 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32957878 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.32204828 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31567768 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31437141 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30979173 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29685071 |
| 114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.29035119 |
| 115 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28375152 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27350855 |
| 117 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27342576 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26476465 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26400963 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22037694 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19503109 |
| 122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18985777 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17595760 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17574006 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15692989 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.15653014 |
| 127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.15512081 |
| 128 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.15097857 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.14131593 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.13800830 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.11968089 |
| 132 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.11557529 |
| 133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.10455451 |
| 134 | Alcoholism_Homo sapiens_hsa05034 | 0.10178762 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.09569720 |

